Page last updated: 2024-09-05

tak 779 and Allergic Encephalomyelitis

tak 779 has been researched along with Allergic Encephalomyelitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, Y; Hou, LF; Ni, J; Ono, S; Tang, W; Tong, XK; Yang, YF; Zhong, XG; Zhu, YN; Zuo, JP	1

Other Studies

1 other study(ies) available for tak 779 and Allergic Encephalomyelitis

Article	Year
The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function. British journal of pharmacology, 2009, Volume: 158, Issue:8 Topics: Amides; Animals; CCR5 Receptor Antagonists; Cell Movement; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, CXCR3; RNA, Messenger; Severity of Illness Index; T-Lymphocytes	2009

Article

Year

The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function.

British journal of pharmacology, 2009, Volume: 158, Issue:8

Topics: Amides; Animals; CCR5 Receptor Antagonists; Cell Movement; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Quaternary Ammonium Compounds; Receptors, CCR5; Receptors, CXCR3; RNA, Messenger; Severity of Illness Index; T-Lymphocytes

2009